CompletedPhase 3NCT01985373

Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml

Studying Primary immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Prothya Biosolutions
Principal Investigator
F P Kroon, PhD, MD
LUMC
Intervention
Intravenous immunoglobulin infusion(drug)
Enrollment
23 enrolled
Eligibility
18 years · All sexes
Timeline
20132015

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01985373 on ClinicalTrials.gov

Other trials for Primary immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Primary immunodeficiency

← Back to all trials